Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV dexamethasone dose comparison for prevention of postoperative sore throat after cesarean section under general anesthesia
IRCT20230716058799N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in Post-extubation sore throat (POST) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: duration of intubation, duration of extubation and 2 more. Started Sep 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20230716058799N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230716058799N1.